MedTrace Logo

Topical Ice-therapy for Intravitreal Injections

NCT05269823 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2025-08-22

No results posted yet for this study

Summary

Purpose: To examine the difference in patient's pain experience in the setting of intravitreal anti-VEGF injections with pretreatment of topical ice-therapy compared with no-ice.

Conditions

  • Anesthesia; Hypothermia
  • Injection Site Irritation

Interventions

OTHER

Ice-therapy

Ice therapy will be provided prior to intravitreal injection provision

OTHER

No Ice-therapy

No additional intervention (i.e.) ice therapy will be provided prior to intravitreal injection provision

Sponsors & Collaborators

Principal Investigators

  • Jade Moon, MD · University of Minnesota

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-04-01
Primary Completion
2025-04-30
Completion
2025-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05269823 on ClinicalTrials.gov